Postprandial metabolomics analysis reveals disordered serotonin metabolism in post-bariatric hypoglycemia

Here are the Postprandial metabolomics analysis reveals disordered serotonin metabolism in post-bariatric hypoglycemia journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.

Analysis of metabolomic data, basic metabolic panel results interpretation, postdoctoral fellow job metabolomics, how to analyse metabolomics data, interpreting basic metabolic panel results, metabolomics metabolic flux analysis, interpreting metabolic panel results, interpreting complete metabolic panel results, national metabolomics data repository, how to analyze metabolomics data.

Postprandial metabolomics analysis reveals disordered serotonin metabolism in post-bariatric hypoglycemia

BACKGROUND. Bariatric surgery is a potent therapeutic approach for obesity and type 2 diabetes but can be complicated by post-bariatric hypoglycemia (PBH). PBH typically occurs 1-3 hours after meals, in association with exaggerated postprandial levels of incretins and insulin. METHODS. To identify mediators of disordered metabolism in PBH, we analyzed the plasma metabolome in the fasting state and 30 and 120 minutes after mixed meal in 3 groups: PBH (n = 13), asymptomatic post-Roux-en-Y gastric bypass (post-RYGB) (n = 10), and nonsurgical controls (n = 8). RESULTS. In the fasting state, multiple tricarboxylic acid cycle intermediates and the ketone β-hydroxybutyrate were increased by 30%-80% in PBH versus asymptomatic. Conversely, multiple amino acids (branched-chain amino acids, tryptophan) and polyunsaturated lipids were reduced by 20%-50% in PBH versus asymptomatic. Tryptophan-related metabolites, including kynurenate, xanthurenate, and serotonin, were reduced 2- to 10-fo ld in PBH in the fasting state. Postprandially, plasma serotonin was uniquely increased 1.9-fold in PBH versus asymptomatic post-RYGB. In mice, serotonin administration lowered glucose and increased plasma insulin and GLP-1. Moreover, serotonin-induced hypoglycemia in mice was blocked by the nonspecific serotonin receptor antagonist cyproheptadine and the specific serotonin receptor 2 antagonist ketanserin. CONCLUSION. Together these data suggest that increased postprandial serotonin may contribute to the pathophysiology of PBH and provide a potential therapeutic target. © 2024, Ferraz-Bannitz et al.

Authors : Ferraz-Bannitz R.; Ozturk B.; Cummings C.; Efthymiou V.; Querol P.C.; Poulos L.; Wang H.; Navarrete V.; Saeed H.; Mulla C.M.; Pan H.; Dreyfuss J.M.; Simonson D.C.; Sandoval D.A.; Patti M.-E.

Source : American Society for Clinical Investigation